Indeed, our studies predict that the rare pathogenic SHIVs derived directly from HIV-1 infected people [30–32] may represent a small subset of variants that are resistant to IFNα inhibition, potentially allowing them to antagonize the early IFN storm and seed the viral reservoir to establish a persistent infection. The gene discussed is IFNA2; the disease is infection.